Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021

6Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

We estimated vaccine effectiveness (VE) against severe COVID-19 during October 2021, using Slovenian surveillance data. For people fully vaccinated with any vaccine in age groups 18–49, 50–64,≥65 years, VE was 86% (95% CI: 79–90), 89% (85–91), and 77% (74–81). Among≥65 year-olds fully vaccinated with mRNA vaccines, VE decreased from 93% (95% CI: 88–96) in those vaccinated≤3 months ago to 43% (95% CI: 30–54) in those vaccinated≥6 months ago, suggesting the need for early boosters.

Cite

CITATION STYLE

APA

Vitek, M. G., Klavs, I., Učakar, V., Serdt, M., Mrzel, M., Vrh, M., & Fafangel, M. (2022). Vaccine effectiveness against severe acute respiratory infections (SARI) COVID-19 hospitalisations estimated from real-world surveillance data, Slovenia, October 2021. Eurosurveillance, 27(1). https://doi.org/10.2807/1560-7917.ES.2022.27.1.2101110

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free